Diabetes :: Indian probiotic yoghurt Dahi linked to slow diabetes development
A daily supplement of the Indian probiotic yoghurt, dahi, may lower the risk of diabetes, says a new study from the home of the dairy product.
Diabetes
Diabetes :: Losing weight and reducing risk of diabetes – Diet and exercise work equally well
Which works best in fighting the risk factors for diabetes ?exercise or diet? Exercise and diet work equally well in reducing the risk factors for diabetes, a new study finds.
Diabetes :: Enzyme may hold key to new treatment of diabetic kidney disease
Northwestern University researchers have found an enzyme, called “ACE2,” may hold the potential to treat diabetic kidney disease, the most common form of kidney disease.The researchers have found low levels of the ACE2 enzyme in kidneys of diabetic mice. When ACE2 was further decreased with an inhibitor drug, kidney disease worsened. Studies are now needed using compounds that increase the level of ACE2 in the kidneys of diabetic mice to see if it reverses or prevents kidney disease.
Diabetes :: Accurate coding is key to preventing potentially serious health complications associated with insulin overdose
Significant errors in insulin dose can result when blood glucose meters are miscoded according to new clinical study. When persons with diabetes use miscoded blood glucose meters to determine how much insulin to take, significant errors in insulin dose can result that may potentially lead to short- and long-term health complications, according to findings of a new study presented at the Sixth Annual Diabetes Technology Meeting in Atlanta, Georgia.
Diabetes :: Benefit of Gluten-Free Diet in Type 1 Diabetic Children With Celiac Disease
Patients with celiac disease showed clinical improvements with a Gluten-Free Diet, GFD reported in a Denmark study. This study was performed to 1) determine the prevalence of celiac disease in Danish children with type 1 diabetes and 2) estimate the clinical effects of a gluten-free diet (GFD) in patients with diabetes and celiac disease.
Diabetes :: Celiac disease common in kids with type 1 diabetes
Earlier studies suggest that children with type 1 diabetes are more likely to have a subsequent diagnosis of celiac disease. However, research is sparse on the risk of subsequent type 1 diabetes in individuals with celiac disease. We sought to determine the risk of subsequent type 1 diabetes diagnosed before the age of 20 years in children and adolescents with celiac disease in a national, general population-based cohort – Jonas F. Ludvigsson, Department of Pediatrics, ?rebro University Hospital, ?rebro.
Diabetes :: Herbal medicine Milk Thistle, Silybum marianum, silymarin helps sugar-control in type II diabetes
Diabetes is a growing health problem. Giving antioxidants is recognised as one way of helping people with diabetes to control their blood sugar levels. The herbal medicine extracted from seeds of the Milk Thistle, Silybum marianum (silymarin) is known to have antioxidant properties and research published this week in Phytotherapy Research shows that this extract can help people significantly lower the amount of sugar bound to haemoglobin in blood, as well as reducing fasting blood sugar levels.
Diabetes :: EC approves use of insulin drug “NovoRapid”
There is new hope of succour for women suffering from pregnancy diabetes with the European Commission (EC) approving the use of insulin drug ”NovolRapid,” as the first modern insulin that has a label stating can be used in pregnancy.
Diabetes :: Counterfeit Test Strips Discovered in United States
If you use, recommend, distribute or sell OneTouch? Brand Test Strips, we want to make you aware that we have recently discovered several incidents of counterfeit OneTouch? Ultra?1, and OneTouch?2 (Basic?/Profile?) Test Strips in the United States — OneTouch.
Diabetes :: Sanofi-Aventis’s Acomplia, rimonabant obesity pill may treat type 2 diabetes
A new obesity pill that helps to control blood sugar levels could treat patients with type 2 diabetes, researchers say. They found that the Sanofi-Aventis drug Acomplia, which is also known as rimonabant, also reduced risk factors for heart disease in patients with type 2 diabetes who had not responded to standard treatments.